Risk of Estrogen-Driven Malignancies in Females on 5-Alpha Reductase Inhibitors

    November 2024 in “ Archives of Dermatological Research ”
    Thomas Z. Rohan, Grace Turchetta, Sherry Yang
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Female Pattern Hair Loss: Therapeutic Update Anais Brasileiros De Dermatologia · 2023
    2. The Efficacy and Safety of Dutasteride Compared with Finasteride in Treating Men with Androgenetic Alopecia: A Systematic Review and Meta-Analysis Clinical Interventions in Aging · 2019
    3. Safety of 5α-Reductase Inhibitors and Spironolactone in Breast Cancer Patients Receiving Endocrine Therapies Breast Cancer Research and Treatment · 2018
    4. 5-Alpha Reductase Inhibitors and Risk of Male Breast Cancer: A Systematic Review and Meta-Analysis International Braz J Urol · 2018
    5. The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men The Journal of Clinical Endocrinology and Metabolism · 2007

    Related research 1

    1. Establishment of Type II 5α-Reductase Over-Expressing Cell Line as an Inhibitor Screening Model Journal of steroid biochemistry and molecular biology/˜The œJournal of steroid biochemistry and molecular biology · 2007